Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid
Graphical abstract
Novel derivatives of nordihydoguaiaretic acid were synthesized and tested for in vitro and in vivo anticancer activity.
Section snippets
Acknowledgments
The authors would like to acknowledge Bhashyam S. Iyengar and William A. Remers for their assistance in the naming and characterization of the compounds described in this Letter. Sponsorship: The study was funded by grant CA017094 from the National Institutes of Health, Bethesda, Maryland, USA.
References and notes (25)
- et al.
Tetrahedron
(1995) - et al.
Antiviral Res.
(2000) - et al.
Antiviral Res.
(2003) - et al.
Antiviral Res.
(2003) - et al.
Bioorg. Med. Chem. Lett.
(2008) - et al.
Cancer Lett.
(2001) - et al.
Toxicon
(2002) The Honest Herbal a Sensible Guide to the Use of Herbs and Related Remedies
(1994)- et al.
Biochemistry
(1989) - et al.
J. Med. Chem.
(2002)
Exp. Hematol.
J. Clin. Invest.
Cited by (20)
Five-Membered Rings With Three Oxygen or Sulfur Atoms in 1,2,3-Positions
2021, Comprehensive Heterocyclic Chemistry IVShooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones
2019, European Journal of Medicinal ChemistryCitation Excerpt :In vitro 15-LOX enzymatic inhibitory activities are expressed as IC50 values of the tested compounds and shown in Table 1. The universal LOX inhibitor, nordihydroguaiaretic acid (NDGA) [48,49] and selective 12/15-LOX inhibitor quercetin [50,51] were used as positive controls for comparison. All ten compounds showed substantial LOX inhibitory activity with IC50 in the range of 3.14–5.92 μM.
Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase
2019, European Journal of Medicinal ChemistryCitation Excerpt :Compounds 5b, 5c, 5d, 5e and 6e, which were predicted to cross BBB in PAMPA assay, were tested for COX-1, COX-2 and 15-LOX inhibitory activity using commercial assay kits. The orally active anti-LOX drug Zileuton ([N-(1-benzo[b]thien-2-ylethyl)-N-hydroxyurea) [88] and the universal LOX inhibitor nordihydroguaiaretic acid (NDGA) [89,90] were used as positive controls for comparison. For COX inhibition assay, the selective COX-2 inhibitor celecoxib and the non-selective COX inhibitors diclofenac and indomethacin were used as references.
Structural characterization of reaction products of caftaric acid and bisulfite present in a commercial wine using high resolution mass spectrometric and nuclear magnetic resonance techniques
2017, Food ChemistryCitation Excerpt :Interestingly, both H2 and H5 on e had identical large downfield shifts (0.69 Hz) leading us to query whether the molecule may have two sulfate groups attached to the C3 and C4 oxygen atoms or a bridging sulfate group across C3 and C4 oxygens, however, the LC-MS data did not support this theory. Furthermore, such a bridging arrangement has been observed in similar lignin-type structures (Meyers et al., 2009; Son, Lee, Nagarapu, & Jahng, 2005), resulting in larger shifts for all aromatic protons (each approx. 0.8 ppm downfield); this was not the case in the present study as H6 only had a 0.14 ppm downfield shift. The conclusion therefore, based on the data available was that the sulfo group in e is attached to the C3 oxygen atom.
Targeting arachidonic acid pathway by natural products for cancer prevention and therapy
2016, Seminars in Cancer BiologyCitation Excerpt :LD50 of a NDGA analog M4N was found at 1000 mg/kg (intraperitoneal injection) whereas LD50 of parent molecule NDGA was found at 75 mg/kg [399]. In another study, tetra-O-substituted NDGA analogs exhibited less toxicity than NDGA [400]. These studies warranted development of less toxic derivatives of NDGA which should be explored as anti-inflammatory and anti-cancer agents.